Market research reports on: DNA, RNA, proteomics, genomics, genetics, cancer, cell, protein, sequencing, biomarkers, peptides, in vitro diagnostics, molecular and others.
Let's ConnectHuman Identification: Forensics, Genealogy and Security Applicati...
The global market for human identification reached $43.0 billion in 2019 and should reach $83.9 billion by 2024, at a compound annual growth rate (CAGR) of 14.3% for the period of 2019-2024.
Strategies for Colloidal Stabilization of Nanoparticles for Life ...
Consumption of nanostructures in the life science sectors (e.g., nanoparticles, nanospheres, nanocapsules, and quantum dots) is projected to be characterized by healthy growth during the next five years. The report provides a detailed description of applications in the medical sector and examines main drivers for market growth within this industry. The global market for nanostructures in life science should reach $17.8 billion in 2019 and is projected to reach $33.8 billion in 2024, registering a CAGR of 13.7% during the five-year period.
Tumor Infiltrating Lymphocytes: A New Frontier in Cancer Immunoth...
This report will assess the latest developments that are taking place with regard to the current research and development environment of TILs and explore the novel strategies companies are adopting to identify and enhance TIL selection, biosynthesis and delivery in a wide range of metastatic cancers including, melanoma, gastrointestinal tract carcinomas, non-small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumors.
Global Stem Cell and Regenerative Therapy Market: A BCC Research ...
The global stem cell and regenerative medicines market should grow from $21.8 billion in 2019 to reach $55.0 billion by 2024 at a compound annual growth rate (CAGR) of 20.4% for the period of 2019-2024.
Global Microbiome Sequencing Market
The global market for microbiome sequencing should grow from $885 million in 2018 to $2.0 billion by 2023 at a compound annual growth rate (CAGR) of 18.2% for the period of 2018-2023.
Global Longevity and Anti-senescence Therapy Market
The global longevity and anti-senescence therapies market should grow from $329.8 million in 2018 to $644.4 million by 2023 with a compound annual growth rate (CAGR) of 14.3% during 2018-2023.
Global Tumor-specific Antigen Market
The global market for tumor-specific antigen should grow from $1.8 billion in 2018 to $2.4 billion by 2023 at a compound annual growth rate (CAGR) of 6.2% for the period of 2018-2023.
Cell Harvesting Market
The global market for cell harvesting should grow from $885 million in 2018 to reach $1.5 billion by 2023 at a compound annual growth rate (CAGR) of 11.3% for the period of 2018-2023.
Cell Viability Assays and Consumables: Global Markets
The global market for cell viability assays should grow from $2.7 billion in 2018 to reach $4.1 billion by 2023 at a compound annual growth rate (CAGR) of 8.3% for the period of 2018-2023.
Validation, Calibration and Standardization in the Life Sciences ...
The global market for validation, calibration and standardization in the global life sciences should grow from $1.5 billion in 2018 to reach $2.1 billion by 2023 at a compound annual growth rate (CAGR) of 6.7% for the period of 2018-2023.
Current Bioprinting Prospects and Future Innovations
The global bioprinting market should reach $1.4 billion by 2024 from $306.2 million in 2019 at a compound annual growth rate (CAGR) of 35.4% for the period 2019 to 2024.
Cell Line and Membrane Market
The global cell line and membrane market should reach $220.3 million by 2023 from $172.0 million in 2018 at a compound annual growth rate (CAGR) of 5.1% for the period 2018 to 2023.
Cancer Profiling and Pathways: Technologies and Global Markets
The global market for cancer profiling technologies should grow from $45.2 billion in 2018 to $90.6 billion by 2023 with a compound annual growth rate (CAGR) of 14.9% for the period of 2018-2023.
Emerging Jobs in Life Sciences and What You Should Be Training fo...
To develop and more importantly to improve current technologies, the market needs a pipeline of talent: well-educated and skilled scientists. Today, a new graduate or scientist with an immunology background will have a strong advantage in the market.The market for NGS applications reached $2.7 billion in 2016 and is expected to expand to $10.5 billion by 2022.The expanding biotech market offers a variety of careers. In some cases, we need to be creative and see behind the obvious scientific path.
Synthetic (Cultured) Meat: Technologies and Global Markets
The global synthetic (cultured) meat market should reach $19.8 million by 2027 from $16.3 million in 2022 at a compound annual growth rate (CAGR) of 4.0% for the period 2022-2027.
Protein Expression: Global Markets
The global market for protein expression should grow from $1.8 billion in 2017 to $3.1 billion by 2022 at a compound annual growth rate (CAGR) of 11.3% from 2017 through 2022.
Cancer Cell Analysis, Instruments, Consumables and Reagents
The global market for cancer cell analysis should reach $10.8 billion by 2023 from $7.4 billion in 2018 at a compound annual growth rate (CAGR) of 7.8% for the period of 2018-2023.
Cell Separation and Characterization in Solid Tumors: Global Mark...
The global market for cell separation and characterization in solid tumors should grow from $1.8 billion in 2018 to reach $3.3 billion by 2023 at a compound annual growth rate (CAGR) of 12.5% for the period of 2018-2023.
Bioprocess Optimization and Digital Bio-manufacturing: Global Mar...
The global market for bioprocess optimization and digital biomanufacturing will grow from nearly $26.5 billion in 2018 to nearly $40.5 billion by 2023 with a compound annual growth rate (CAGR) of 8.9% for the period of 2018-2023.
Biomarker Deals: Terms, Value and Trends, 2008-2018
Over the last decade, biomarker research has become one of the essential aspects not only of the in vitro diagnostics industry but an important component of the drug discovery and development process. Moreover, with the growing trend in personalized medicine and companion diagnostics, the use of biomarkers is becoming obligatory in management of certain diseases, such as cancer drug regimen.
Chromatography in Pharmaceuticals and Biotechnology: Global Marke...
The global market for chromatography instruments and reagents should grow from $9.8 billion in 2018 to $14.0 billion in 2023 at a compound annual growth rate (CAGR) of 7.3% from 2018 to 2023.
Protein Analysis: Subfocus on Oncoproteomics
The global market for protein analysis should grow from $11.6 billion in 2018 to $19.0 billion by 2023 at a compound annual growth rate (CAGR) of 10.4% from 2018 through 2023.
Genetic Modification Therapies Clinical Applications: Gene Thera...
The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.
Next Generation Sequencing for Non-invasive Prenatal Testing: Glo...
The global market for non-invasive prenatal testing (NIPT) should grow from $1.9 billion in 2018 to reach $3.1 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2018-2023.
Switching to CRISPR-Cas Systems from Uncultivated Microbes
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is currently the biggest discovery in life science. As a precise gene editing tool, it has been widely used in many areas with a great potential to treat human diseases. While some CRISPR-based therapeutic studies are moving to clinical trials, CRISPR's therapeutic promise was brought into question when some issues were found that could become major obstacles in moving the great genome editing tools to the clinic.While many groups are actively resolving these obstacles, the significant challenges to minimize the immunological risks and avoid potential tumorgenicity have received more attention as big concerns for CRISPR-Cas therapeutics advancing toward the clinic. We believe it is timely to summarize and analyze the emerging immunological risk and potential tumorgenicity with the CRISPR-Cas systems, to predict how this exciting genome editing market will affect other related segments of the entire life science market in the next few years. We also hope our opinion could serve as a "crowd crystal" on those discussions in response to the issues, and bring a better market environment for the technology to be sharpened and advanced into clinical applications.
Choose your License
RNA Sequencing: Technologies and Global Markets
This report provides an overview of the RNA sequencing industry and its competitive landscape. Leading market players' profiles, product offerings, financial information, and recent market activities are provided.
AI in Clinical and Molecular Diagnostics Market
This report explains critical trends in AI in clinical and molecular diagnostic industry. The report examines market determinants that serve as driving or inhibiting factors, offering valuable insights to stakeholders and potential entrants.
Cell and Gene Therapy Tools, and Reagents: Global Markets
This report provides a comprehensive analysis of product types, applications, and end-users of cell and gene therapy tools and reagents, along with a critical perspective of the industry's trends, future potential, and direction.
Commercial Amino Acids
This report outlines the properties of the 20 commercial essential amino acids that are delineated in the genetic code.
Induced Pluripotent Stem Cells: Global Markets
This report focuses on the market size and segmentation of iPSC products, including iPSC research and clinical products.
Global DNA Sequencing: Research, Applied and Clinical Markets
This report aims to provide detailed market, technology, and industry analyses to help readers quantify and qualify the market for DNA sequencing. Important trends are identified, and sales forecasts by technology, product & services, end-user, application, and disease category are provided through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The report discusses single-use technologies and bioreactors to produce pharmaceuticals and provides in-depth market analysis.